Guest guest Posted January 21, 2008 Report Share Posted January 21, 2008 DEGREES B.S., Chemistry and Biological Sciences, Stanford University, Stanford, Ca. 1980 M.Phil., Pharmacology, City University of New York, N.Y., N.Y. 1984 Ph.D., Pharmacology, City University of New York, N.Y., N.Y. 1986 M.D., M.D.-Ph.D. program, Mount Sinai School of Medicine, N.Y. 1987 Ph.D. THESIS Studies on the Effects of Inhibitors of TR4-degrading Enzymes 1982-1985. Preceptor: Sherwin Wilk, Ph.D. Department of Pharmacology, Mount Sinai School of Medicine TRAINEESHIPS RESIDENCY at University of Michigan Hospitals, 1987-1989 Internal Medicine Ann Arbor, MI. FELLOWSHIP at National Institutes of Health, National Institute of Child Health and Human Development, Bethesda, MD. 1989-1992 Endocrinology SENIOR STAFF FELLOW at National Institutes of Health, National Institute of Child Health and Human Development, Bethesda, MD. 1992-1995 Endocrinology HONORS Graduated with Distinction from Stanford University 1980 Doctoral Dissertation Award for best thesis, Mount Sinai School of Medicine 1986 NIH Student Exchange Program-Elective in Endocrinology 1986 Hadassah Hospital Student Exchange Program, Jerusalem, Israel 1987 <http://goodhormonehealth.com/meet_dr/Friedman_cv.html#CURRICULUM_VITAE> PROFESSIONAL EXPERIENCE POSITIONS HELD UCLA School of Medicine 2005- Chief, Division of Endocrinology, Metabolism and Molecular Medicine, R. Drew <http://www.cdrewu.edu/com/internal_medicine/endocrinology/faculty_research.htm>\ University of Medicine and Science. UCLA School of Medicine 2000- Associate Professor of Medicine-In-Residence Level 3 Endocrinology Division R. Drew University of Medicine & Science Los Angeles, CA Luther King Medical Center 2000- Director, Endocrinology Fellowship Program R. Drew University of Medicine & Science 2000- Director, Body Composition Core of the Drew Center of Excellence for Metabolic Research UCLA School of Medicine 1995-2000 Associate Professor of Medicine-Level 4 Endocrinology Division, Cedars-Sinai Medical Center Los Angeles, CA Cedars-Sinai Medical Center 1998-2000 Director, Multi-Disciplinary Chronic Fatigue Clinic COMMITTEE SERVICE Cedars-Sinai Medical Center Education Committee 9/96-2000 Cedars-Sinai Medical Center Medical Informatics QAT 9/97-2000 R. Drew University Animal Care Committee 2000- <http://goodhormonehealth.com/meet_dr/Friedman_cv.html#CURRICULUM_VITAE> MEMBERSHIPS Endocrine Society 1990- Los Angeles Cross Town Endocrine Club 1995- American Diabetes Association 1996- AACFS 2002- Los Angeles Reproductive Endicrinology Club (founder and president) 2002- EDITORIAL ACTIVITIES Ad-hoc reviewer for: Endocrinology 1/95- Journal of Clinical Endocrinology and Metabolism1/95- Peptides 1/95- Pharmacology Biochemistry and Behavoir 6/97- Journal of Clinical Investigation 7/00- Journal of Molecular Endocrinology 12/01- Diabetes Care 1/03- GRANT REVIEWER Ad-hoc reviewer for Canadian Diabetes Association 2000 Ad-hoc reviewer for IFCN-2 Study section 2000 Reviewer for Special Study Section on Gene Therapy and Diabetes 2001 Ad-hoc reviewer for the Hospital for Sick Children Foundation 2001 Mail reviewer for CEBRA (Cutting Edge Basic Research Awards- NIDA 2003 AWARDS AND RECOGNITION " Endocrinology Under 35 " Meeting, Best Poster Award,Rapallo Italy 1992 Outstanding Achievements in Promoting Black Employees Award 1993 E. Culpeper Foundation Research Fellow 1996-1998 Mentor Drew Magnet High School Program 2000- Mentor of Melo Yap, 3rd place winner of the Biochemistry category, LA County Science Fair for high school students. 2001 LICENSURE & BOARD CERTIFICATION California State License #G81765 1995- DEA # BF4533495 Board Certified, Internal Medicine 1990 Board Certified, Endocrinology, Diabetes and Metabolism 1993 <http://goodhormonehealth.com/meet_dr/Friedman_cv.html#CURRICULUM_VITAE> RESEARCH GRANTS RESEARCH GRANTS RECEIVED NIH S06GM068510-01 Minority Biomedical Research Support . Program Director-Friedman MBRS Score Program at R. Drew University of Medicine & Science. 8/1/03-7/31/07. Direct costs $2,046,034/Total costs $2,906,743. NIH R24DA017298-01-A1 Program Director-Friedman MIDARP Program at R. Drew University of Medicine & Science. 12/1/03-11/30/08. Direct costs $1,750,000/Total costs $2,502,500. NIH 1U54 HD41748-01 PI -Friedman Physiologic testerone Replacement in Women with Hypopituitarism. (part of reproductive Center of Excellence entitled " Biologic Effects of Androgens in Men and Women " ) 3/1/03-2/29/08. Direct costs $1,250,000/ Total costs $1,768,750. CFIDS Association of America Research Grant, PI-Friedman. Decreased Cerebral Blood Flow and Orthostasis in CFS. 2/1/03-1/31/04. Direct costs $72,727/Total costs $80,000. NIH R01DA14659-01A1, PI-Friedman Genes and Proteins Leading to Addiction. 8/1/02-7/30/07. Direct costs $750,000, Total costs $1,068,750. NIH R21DA15466-01-A1 PI-Friedman HPA axis activation and nicotine use. 4/1/03-3/31/06. Direct costs $3000,000/Total costs $427,500. NIH-R21DA016867-01-A1 PI-Friedman Chronic Nicotine's Activation of the HPA Axis 7/1/03-6/30/06. Direct costs $300,000/Total costs $427,500. NIH-Construction Grant, Co-applicant (PI:Francis/Norris) Exrtamural Research Facilities Construction (clinical research). 9/1/02. Direct costs $3,000,000/Total costs $3,000,000. NIH-Construction Grant, Co-applicant (PI: Francis/Norris) Extramural Research Facilities Construction (basic research) 2/1/03. Direct Costs $4,000,000/Total costs $4,000,000. NIH- Animal Care Facility Grant, Co-applicant (PI-Norris) Animal Care Facility/Transgenic-Phenotyping Mouse Program Enhancement-Supplement to RCMI Biomedical Research Center G12-RR03026-15 9/1/02-8/31/03. Direct costs $200,000/Total costs $200,000. Pfizer Grant on uses of Viagra, PI-Friedman Use of Sildenafil (Viagra®) to Improve Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients with Chronic Fatigue Syndrome 5/1/02-12/31/03. Direct costs $50,000/Total costs $435,000. NIH-P20 RR11145-01 (Center of Excellence Grant), Co- investigator (PI-Francis/Norris). Regulation of Prohormone Convertases. 5/1/00-4/30/04. Direct costs $300,000/Total costs $435,000. NIOSH-1R01OH007575-01, Co-Investigater (PI: Robbins) Male Reproductive Effects from Exposure to Boron 9/30/01-9/29/06, Direct costs $380,790/year. Thyroid Research Advisory Council (TRAC) Research Grant, PI Regulation of PC1 and PC2 by Thyroid Hormone 7/1/00-6/30/02 Direct Costs $86,956/Total Costs $100,000 NIDA K21 DA00276-01, PI-Friedman Structural Determinants in Regulation of POMC Processing 7/1/95- 6/30/01 Direct Costs-$667,628/Total Costs $721,038 Columbia Research Laboratories Clinical Study, Co-Investigator Phase III study of Buccal Testosterone COL-1621 1/1/01-12/30/01 Direct Costs $61,200/Total Costs $76,250 Columbia Research Laboratories Clinical Study, Co-Investigator An Open-label, Phase III, Multicenter Study of COL-1621, a Bioadhesive Buccal (in the mouth) Testosterone Tablet, for the Long-term Safety, Tolerability and Efficacy in Testerone Deficient Patients. 6/1/01-12/30/02. Direct costs $36,000/Total costs $45,000. E. Culpeper Foundation Research Award, PI-Friedman. Structural Determinants in Regulation of Pro-opiomelanocortin Processing:Implications for Developing Novel Treatments for Drug Addiction 7/1/96- 6/30/98 Direct Costs-$200,000/Total Costs $200,000 ADA Research Grant, PI-friedman Disordered IGF-I Biosynthesis: Implications in the Pathogenesis of Diabetic Complications 1/1/96- 12/31/97 Direct Costs-$100,000/Total Costs $100,000 RESEARCH GRANTS SUBMITTED NIH RO1,1 RO1 DA015769-01-A2, PI ( to be resubmitted 11/03) Regulation of PC1/PC2 by Opiates 11/1/02-10/31/05 Direct costs $525,000/Total Costs 748,125 NIH RO1,PI , Renin-Aldosterone axis in CFS (recieved a score of 260, will be resubmitted) 2/1/03-1/31/06. Direct Costs $525,000/Total Costs $748,125 LECTURES AND PRESENTATIONS, (SELECTED) 1.. University of Michigan Medical Center-Endocrine Research Conference-March 10, 1994. In Vitro Processing of Pro-opiomelanocortin and Anthrax Toxin Protective Antigen by Recombinant PC1 2.. NIH Inter-institute Endocrine Grand Rounds-April 8, 1994. In Vitro Processing of Pro-opiomelanocortin and Anthrax Toxin Protective Antigen by Recombinant PC1: Implications for Endocrine Tumor Targeting 3.. Eli Lilly Endocrine Noon Conference-April20, 1994. In Vitro Processing of Pro-opiomelanocortin and Anthrax Toxin Protective Antigen by Recombinant PC1 4.. University of Colorado Medical Center- Clinical Pharmacology Seminar-July 21, 1994. In Vitro Processing of Pro-opiomelanocortin and Anthrax Toxin Protective Antigen by Recombinant PC1: Implications for Endocrine Tumor Targeting 5.. National Heart Lung and Blood Institute Seminar-August 17, 1994. Processing of Pro-opiomelanocortin by PC1 and PC2: Implications for Processing Vasoactive Peptide Precursors 6.. Cedars-Sinai Medical Center Special Research Seminar-December 1, 1994. Processing of Pro-opiomelanocortin by PC1 and PC2: Insights from In Vitro and Antisense Experiments 7.. Cedars-Sinai Medical Center EndocrinologyResearch Seminar-May 19, 1995. The Endocrinology of Sleep 8.. Institute de Biotechnologia/UNAM Seminar-Cuernavaca, Mexico- February 6, 1996. Biosynthesis and Processing of TRH 9.. Cedars-Sinai Medical Center EndocrinologyResearch Seminar- February 9, 1996. Biosynthesis and Processing ofTRH 10.. Harbor-UCLA Medical Center Clinical Endocrinology Conference- March 13, 1996. Cushing Syndrome Versus Pseudo-CushingState- What to do? 11.. Cedars-Sinai Medical Center Endocrine Grand Rounds-April 16, 1996. Cushing Syndrome Versus Pseudo-Cushing State-What to do? 12.. Hammersmith Hospital-Endocrinology Research Seminar-London, England-August 5, 1996. Prohormone Processing 13.. University of Reading-Biochemistry and Physiology of Disease Research Group-Reading, England-August 8, 1996. POMC and ProTRH Processing 14.. University of Bristol Medical Center-Department of Medicine Seminar-Bristol, England-August 12, 1996. The Endocrinology of Sleep 15.. Royal Free Hospital-Endocrinology Research Seminar-London, England-August 13, 1996. Pro-Hormone Convertases 16.. Cedars-Sinai Medical Center Endocrinology Research Seminar- September 27, 1996. Pro-hormone Processing:Advances in Basic Science and Clinical Studies 17.. University of Southern California Medical Center Endocrinology, Diabetes and Hypertension Grand Rounds-October 1, 1996. Pro- hormone Processing:Advances in Basic Science and Clinical Studies 18.. City of Hope National Medical Center Diabetes, Endocrinology and Metabolism Clinical Conference-October 2, 1996. Cushings Vs. PseudoCushings-How to Differentiate? 19.. Wadsworth VA Medical Center Endocrine Research Seminar-October 24, 1996. Prohormone Processing:Advances in Basic Science and Clinical Studies 20.. Cedars-Sinai Medical Center Endocrinology Journal Club-December 13, 1996. Two-Hybrid System 21.. UCLA Interdisciplinary Pituitary Conference-January 16, 1997. Discussant on Recurrent or Persistent Cushing's Syndromein a 21 year old Woman 22.. Mount Sinai School of Medicine Endocrinology Grand Rounds-February 18, 1997. Prohormone Processing:Advances in Health and Disease 23.. The New York Hospital-Cornell Medical Center Division of Endocrinology, Diabetes and Metabolism Weekly Conference-February 19, 1997. Prohormone Processing:Advances in Basic Science and Clinical Studies 24.. Cedars-Sinai Medical Center Endocrine Grand Rounds-March 4, 1997. Processing Enzymes in Health and Disease 25.. Cedars-Sinai Medical Center Medical Genetics Seminar-March 13, 1997. Prohormone Processing:Advances in Basic Science and Clinical Studies 26.. Cedars-Sinai Medical Center Endocrine Grand Rounds-March 25, 1997. The Endocrinology of Sleep 27.. Cedars-Sinai Medical Center Endocrinology Research Seminar- October 31, 1997. Genes Involved in Spermatogenesis 28.. UCLA Interdisciplinary Pituitary Conference-November 20, 1997. Growth Hormone Deficiency 29.. Cedars-Sinai Medical Center Endocrine Grand Rounds-January 13, 1998. The Endocrinology of Fatigue 30.. UCLA Interdisciplinary Pituitary Conference-May 28, 1998. Problems in the Diagnosis of Cushing's Syndrome 31.. R. Drew Endocrine Clinical Conference-June 10, 1998. Endocrinology of Fatigue 32.. Endocrine Society " Meet the Professor " -June 24, 1998. Cushing's Syndrome 33.. Cedars-Sinai Medical Center Endocrine Grand Rounds-September 15, 1998. Cushings vs Pseudocushings 34.. California Pituitary Conference -October23, 1998. Cushing's Disease 35.. Cedars-Sinai Medical Center Endocrinology Research Seminar- November 6, 1998. Regulation of the Prohormone Convertases:A Novel Mechanism to Maintain Hormonal Homeostasis 36.. Cedars-Sinai Medical Center Endocrine Grand Rounds-February 23, 1999. The Endocrinology of Chronic Fatigue 37.. Cedars-Sinai Medical Center Endocrine Grand Rounds-May 11, 1999. Prohormone Processing 38.. UCLA Interdisciplinary Pituitary Conference-September 30, 1999. Repeat Surgery, Radiation or Adrenalectomy in Recurrent Cushing's Syndrome 39.. Cedars-Sinai Medical Center Endocrine Grand Rounds-October 5, 1999. Update on Cushing's Syndrome 40.. California State University-LA Biology and Microbiology Seminar- November 2, 1999. Regulation of the Prohormone Convertases: A Novel Mechanism to Maintain Hormonal Homeostasis 41.. R. Drew Endocrine Clinical Conference-January 6, 2000. Regulation of the prohormone convertases: A novel mechanism to maintain hormonal homeostasis in Diabetes 42.. University of Southern California Medical Center Division of Endocrinology and Diabetes Grand Rounds-February 1, 2000. Regulation of the prohormone convertases: A novel mechanism to maintain hormonal homeostasis in Diabetes 43.. Harbor-UCLA Medical Center Clinical Endocrinology Conference- February 23, 2000. Regulation of the prohormone convertases: A novel mechanism to maintain hormonal homeostasis in Diabetes 44.. Cedars-Sinai Medical Center Endocrinology Research Seminar- February 25, 2000. Regulation of the prohormone convertases: A novel mechanism to maintain hormonal homeostasis in Diabetes 45.. Wadsworth VA Medical Center Endocrine Research Seminar-June 9, 2000. Endocrinology of Chronic Fatigue. 46.. MLK/Drew Pathophysiology Lecture Series-June 19, 2000. The Adrenal Gland. 47.. R. Drew Endocrine Clinical Conference-June 28, 2000. Endocrinology of Chronic Fatigue. 48.. R. Drew Emergency Medicine Conference-September 11, 2000, Adrenal Insufficiency. 49.. City of Hope Endocrine Clinical Conference- September 13, 2000, Endocrinology of Chronic Fatigue. 50.. R. Drew Endocrine Clinical Conference-February 21, 2001, Diagnosis of Difficult Cases of Cushing's Syndrome. 51.. Providence Holy Cross Medical Center Clinical Conference-March 27, 2001, The Practical Evaluation and Management of Adrenal Insufficiency for the Hospitalist and the Primary Care Physician. 52.. R. Drew Endocrine Basic Conference-July 23,2001, Hormones Involved in Obesity/Role of 7B2. 53.. National Youth Leadership Forum on Medicine-July 25, 2001, Careers in Academic Medicine. 54.. R. Drew Internal Medicine Grand Rounds-September 12, 2001, Adrenal Insufficiency. 55.. Cedars-Sinai Medical Center Endocrinology Research Seminar-November 27, 2001, Endocrinology of Chronic Fatigue. 56.. R. Drew Endocrine Clinical Conference-February 20, 2002 How to Diagnosis Early Cushing's. 57.. City of Hope Endocrine Clinical Conference- June 5, 2002 Adrenal Insufficiency. 58.. Pituitary Patient Congress (sponsored by the Pituitary Network Association) June 27, 2002 The Logical Progression: Building your own best team for rest of life care. 59.. Pituitary Patient Congress (sponsored by the Pituitary Network Association) June 28, 2002 Cushing's Syndrome (session chair and keynote speaker). 60.. National Youth Leadership Forum on Medicine-July 10, 2002 Careers in Academic Medicine. 61.. R. Drew Internal Medicine Grand Rounds-September 19, 2002 Endocrinology of Chronic Fatigue. 62.. King Drew Medical Center New Technologies in Medicine Conference-October 25, 2002 New Technologies in Endocrinology. 63.. Harbor-UCLA Medical Center Clinical Endocrinology Conference-November 5, 2002 Everything you Need to Know to Diagnose Cushing's Syndrome. 64.. Cedars-Sinai Medical Center Endocrinology Grand Rounds-March 4, 2003 Renin/Aldosterone Axis in Chronic Fatigue Syndrome. 65.. West LA VA Medical Center Endocrine Research Seminar-March 14, 2003 Cushing's Syndrome. 66.. Women's Sexual Health State-of-the-Art Series (Santa , CA)-March 16, 2003. Assays and Measurement Issues: Can Androgen Deficiency Be Reliably Addressed in Women? 67.. Harbor-UCLA Medical Center Internal Medicine Grand Rounds-April 1, 2003 Comprehensive Hormone Replacement in Patients with Hypopituitarism. 68.. UCLA Pituitary Patient Care Support-April 10, 2003 Hormone Replacement in Patients with Hypopituitarism-We Simply Need to Do More. 69.. R. Drew Endocrine Clinical Conference-May 21, 2003 Nuances of Hormone Replacement for Hypopituitarism-part I. 70.. R. Drew Endocrine Clinical Conference-June 4, 2003 Nuances of Hormone Replacement for Hypopituitarism-part II. 71.. New Jersey Medical School-War Related Illnesses Special Conference- June 25, 2003 Endocrine Causes of Chronic Fatigue. 72.. R. Drew Endocrine Division of Research Grant Writing Series-July 21, 2003-Specific Aims and Hypothesis. 73.. R. Drew Endocrine Division of Research Grant Writing Series-July 28, 2003-Background and Preliminary Data. 74.. R. Drew Endocrine Division of Research Grant Writing Series-August 4, 2003-Methods. 75.. R. Drew Endocrine Division of Research Grant Writing Series-August 18, 2003-Resubmissions. 76.. West LA VA Medical Center Endocrine Research Seminar-September 4, 2003 Nuances of Hormone Replacement for Hypopituitarism-part I. 77.. Cedars-Sinai Medical Center Endocrinology Grand Rounds-September 30, 2003 Nuances of Hormone Replacement for Hypopituitarism-part I 78.. Cedars-Sinai Medical 7Center Endocrinology Grand Rounds-October 14, 2003 Nuances of Hormone Replacement for Hypopituitarism-part II 79.. Providence Holy Cross Medical Center Clinical Conference-October 21, 2003 Diagnosis & Management Of Adrenal Insufficiency In Hospitalized Patients. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.